← Back to headlines
Axsome Projects Auvelity Peak Sales of at Least $8B
Axsome Therapeutics projects peak sales for its drug Auvelity to reach at least $8 billion, following its approval for Alzheimer's agitation and an anticipated June launch.
4 May, 19:45 — 4 May, 19:45
Sources
Showing 1 of 1 sources
